Objective: This study explored the clinical efficacy and hemodynamic effects of the micropore stent graft (MSG) that could promote aortic remodeling and preserve important organ branches.
pericardial tamponade, and tissue ischemia, and its mortality rate is extremely high. 2 Thoracic endovascular aortic repair has become an accepted alternative to surgery for the treatment of AD. 3 This strategy is suitable for most patients because it is a minimally invasive procedure with fewer perioperative complications and lower mortality rates. However, endovascular treatment is not suitable for all patients.
According to the literature, the current management of complex thoracic aortic dissection (TAD) requires a hybrid approach for acceptable early and midterm major morbidity and mortality (12%); however, there is still a high rate of reintervention (24%) and endoleak (18%). 4 Endovascular repair for aortic arch disease remains challenging because of the limited length of the landing zone while preserving the supra-aortic branch blood flow. 5 To more effectively address this patient population, the micropore stent graft (MSG) was independently developed in China to treat complex TAD. This membranecovered stent has micropores on its wall, and the principle underlying the application of this type of stent is similar to that of the multilayer flow modulator (MFM) stent (Cardiatis, Isnes, Belgium). The concept of flow diversion involves a commercial multilayer MFM stent that has been used to treat TAD in situations where the patients were not suitable for standard endovascular repair. 6 Unlike a conventional stent graft, flow diversion acts as a passive barrier by reducing blood flow into the false lumen and subsequently creates a natural hemodynamic environment to promote false lumen thrombosis, which is conducive for the activation and aggregation of platelets within the false lumen. 7, 8 Moreover, the stent can fully maintain the patency of important branch vessels and avoids organ ischemic infarction and spinal ischemia. The purpose of the current study was to analyze midterm follow-up outcomes in 26 patients who were treated for DeBakey type I and type III TAD using MSG. This study also explored the clinical efficacy and hemodynamic effects of novel treatment regimens that could promote aortic remodeling and preserve important organ branches. 9 
| Stent structure
The MSG (Aortec Technology Co., Ltd., Beijing, China) ( Figure 1 ) is approved by the China Food and Drug Administration to treat TAD and aortic aneurysm in China. Its features include a conical thoracic aortic membrane-covered stent that is suitable for TAD with a compressed true lumen. The stent is based on a porous membranecovered stent graft and is a cylindrical or conical stent graft designed to seal the main tear in TAD. In this study, the stents were made of a nickel-titanium alloy, and the surface was covered with a membranous layer of polyester fibers with 1.3 mm micropores (average 3 micropores/cm 2 ). The lengths of the stents ranged from 80 to 200 mm, the proximal diameters ranged from 22 to 46 mm, and the distal diameters were 3-8 mm smaller than the proximal diameter. A 20F or 22F sheath was required for stent delivery. 
| Diagnosis and treatment

| Volume calculated
In the professional workstation, the CTA imaging data in DICOM format were imported into the Mimics 19.0 medical image processing program (Materialise Inc., Belgium) to reconstruct a 3D model of the target vessel and calculate volume. 4 
| Hemodynamic analysis of the cardiac cycle in individual-based model
This assessment defined the blood as a mobile fluid to study the influence of blood on the blood vessel wall at different phases of the cardiac cycle. The following assumptions were used in the numerical simulation: the blood vessel wall was rigid and no-slip; and blood was incompressible Newton fluid. The movement viscosity coefficient of blood was u = 0.0035 PaÁS, the blood density was p = 1,050 kg/m 3 Two typical time points were selected for analysis: T 1 = 0.25 s, the blood flow velocity was at a fast speed, which was equivalent to the rapid ejection period of the heart; T 2 = 0.3 s, the blood flow velocity reaches the peak, which was equivalent to the maximum systolic period of the ventricle. Hemodynamic analysis of the cardiac cycle were based on data presented by Stefanov et al. 12 Six patients (nine covered branches) completed a 24-month follow-up. The patency rate in important branches was 100% (9/9).
| Follow-up
No stroke or paraplegia was reported. Five of these six (83.3%) patients presented with complete false lumen thrombosis, and five (100%) had a false lumen thrombus that was completely absorbed and showed aortic remodeling.
The ratio of the mean true lumen volume to the mean total volume was 0.560, 0.620, 0.684, 0.788, 0.853, and 0.956 before and at 1, 3, 6, 12, and 24 months after surgery, respectively. Figure 2 presents the F I G U R E 2 Panels A, B, C, and D show the changes in mean true lumen volume, mean false lumen volume, mean thrombus volume, and mean total volume between preoperative and postoperative time points average volume change of the true lumen, false lumen, residual blood flow, and total volumes.
During the follow-up period, six patients had partial thrombosis.
Of these patients, two had a type Ib endoleak, perhaps because the distal portion of the micropore stent was fixed above the celiac trunk due to the involvement of the splanchnic vessels of the abdominal aorta, causing the retrograde flow of the distal abdominal aorta. No type Ia or type III endoleaks were reported in this study.
The changes in pressure on the thoracic aortic wall before and after operation suggested that the wall pressure of the false lumen was higher in phases T1 and T2 and that the wall pressure rapidly and progressively decreased after phase T2. High wall shear stress was This study demonstrated that in patients with TAD whose false lumen has a tumor-like change, it was necessary to repair the tear of intima, which could greatly reduce the risk of a rupture. The MSG acts as a passive barrier by reducing blood flow into the false lumen and subsequently creating a natural hemodynamic environment to promote false lumen thrombosis. The velocity and flux of blood flow decreased rapidly in a short time, and the impact on the thoracic aortic wall decreased rapidly. Therefore, the degree of pressure in the false lumen decreased significantly after surgery compared with that before surgery ( Figure 3 ). After the operation, wall shear stress was significantly lower at the direct initial tear and in the false lumen (Figure 4 ).
Before the operation, the vortex and reflux flow appearing in the aorta from the primary entry were increasing. After the operation, the blood flow velocity in the false lumen greatly and progressively decreased ( Figure 5 ). The degree and range of unstable blood flow in the false lumen decreased significantly after surgery compared with those before surgery. As an increasing number of platelets adhered to the inner wall, a thrombus would form in the false lumen, which was beneficial to the self-healing of the intimal tear in the dissection. After the operation, progression from gradual thrombosis to gradual reabsorption corresponded to progression from gradual reduction to complete disappearance of blood flow in the false lumen.
| DISCUSSION
Endovascular repair has become the preferred treatment for TAD.
However, patients with complex TAD, in which the lesions are adjacent to the major branch arteries and the stent docking area is less than 1.5 cm, are not indicated for conventional endovascular repair.
Therefore, for complex TAD that involves important organ branches, regardless of the surgical method chosen, the major problems remain the high mortality rate, spinal cord ischemia, and the blood supply of the affected branch artery. There is currently no effective treatment regimen for this condition.
F I G U R E 3
The analysis of pressure before and after stent-graft placement. Case A represents the preoperative lumen; case B represents the postoperative lumen at 3 months after surgery; and case C represents the postoperative lumen at 6 months after surgery
Recently, a growing body of evidence has shown that rather than providing the patient with safe aortic repair, the intraluminal seal of the TAD increases the pressure in the false lumen, leading to an iatrogenic increase in the risk of TAD rupture. 15, 16 F I G U R E 5 The analysis of streamlined tracking of blood flow velocity field before and after stent-graft placement. Case A represents the preoperative lumen; case B represents the postoperative lumen at 3 months after surgery; and case C represents the postoperative lumen at 6 months after surgery F I G U R E 4 The analysis of wall shear stress on the thoracic aortic wall before and after stent-graft placement. Case A represents the preoperative lumen; case B represents the postoperative lumen at 3 months after surgery; and case C represents the postoperative lumen at 6 months after surgery
The main purpose of any regimen is to prevent the rupture of the TAD and ensure the patency of the important branch vessels and the perfusion of the corresponding organs. 14, 17 A MFM is a multilayer bare stent system used in the endovascular repair of AD. Unlike previous stents, this type does not completely seal the tear in the dissection. Instead, it reduces the shear stress on the vessel wall, and therefore the risk of rupture, by adjusting hemodynamics to delay lesion repair. This type of stent therefore does not affect the blood supply of the branch arteries of the affected organs. 18 However, the MFM is not yet available in the Chinese market. We found that the hemodynamic analysis before and after stentgraft placement showed that the pressure of the false lumen was basically equal to that of the true lumen due to the pressure transferred from the intimal tear in the dissection. Continuous relaxation and contraction gradually damages the thoracic aortic wall structure as the arterial wall progressively thins; the wall pressure thus increases, consequently leading to a higher risk of thoracic aortic wall rupture. After stent-graft placement, the pressure in the dissection was transferred to the MSG, and the peak value and fluctuation of the transfer pressure were lower than that of the direct initial tear, which was helpful in reducing the possibility of a dissection rupture (Figure 3 ). Our study found that the placement of overlapping stents was more effective in reducing flow velocity and shear stress near the thoracic aortic wall (Figures 4 and 5) . The results revealed that it could effectively decrease the dissection from the mainstream blood flow, which may induce thrombus formation inside the false lumen. Therefore, this device may induce a shear gradient-dependent platelet aggregation mechanism 19 within the false lumen.
Moreover, these stents do not isolate the false lumen but instead maintain blood communication with the true lumen. Ultimately, the aortic blood flow reaches a dynamic balance, which prevents the pressure on the false lumen from increasing. As the pressure in the false lumen wall decreases, the risk of rupture of TAD is reduced accordingly. Furthermore, decreasing the blood flow velocity in the false lumen and reducing wall shear stress promote thrombosis in the false lumen. 20, 21 These outcomes suggest that the micropore stent is a safe and effective device for treating complex TAD. Compared with traditional endovascular treatments, the micropore stent also provides many other advantages when used to treat complex TAD. For example, it does not require the physician to measure or calculate the position, diameter, or angle of the important branches before determining where to place the stent.
The advantages of the micropore stent are as follows. The stent allows the blood flow of important branch arteries to be maintained and changes the blood flow from a turbulent flow to a laminar flow by altering hemodynamics. These changes reduce the blood flow velocity through the micropores of the stent, thereby reducing the shear stress applied to the wall of the false lumen and promoting thrombosis in the aortic false lumen. We observed thrombus absorbance and in some cases disappearance, indicating that aortic remodeling was complete. Moreover, MSG reinforces the vessel wall and reduces the risk of rupture in the covered vessel. 13, 22 Our results are consistent with these conclusions. We found that after the micropore stent was placed, a false lumen thrombus gradually formed, and the volume of the true lumen gradually increased. The volume of the true lumen significantly increased during the first 1-3 months after surgery, after which it increased more slowly. The residual blood flow in the false lumen gradually decreased until it completely subsided ( Figure 6 ).
Over time, the relative changes observed in true lumen volume, false lumen residual blood flow, and false lumen thrombus volume significantly affected the remodeling of the diseased aorta. The thrombus in the false lumen increased until it reached a stable state, after which the absorbance of the thrombus began, and the thrombus then shrank or even disappeared. However, aortic remodeling occurs when the patency of important branch vessels is maintained. Therefore, the micropore stent likely exerts positive effects by reducing the risk of dissection and accelerating aortic remodeling.
| CONCLUSIONS
In the current study, we demonstrate that the micropore stent, when used to treat TAD, works by gradually promoting aortic remodeling.
The micropore stent is a feasible and reliable option for treating complex TAD in Mainland China. Its application will completely change the treatment methods currently used to repair complex TAD in this region.
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